Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Y-mAbs Therapeutics, Inc. (YMAB) had Pre-Tax Income of $-6.65M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$18.46M |
|
$-7.00M |
|
$2.25M |
|
$16.21M |
|
$27.03M |
|
$-8.57M |
|
$1.92M |
|
|
Pre-Tax Income |
$-6.65M |
$-6.65M |
|
$-7.00M |
|
$-7.00M |
|
$-7.00M |
|
$-7.00M |
|
$-8.57M |
|
$-8.45M |
|
44.63M |
|
44.63M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$99.06M |
|
$0.05M |
|
$21.86M |
|
$120.92M |
|
$25.29M |
|
-- |
|
$3.20M |
|
$28.49M |
|
$92.43M |
|
$90.06M |
|
$92.43M |
|
44.77M |
|
| Cash Flow Statement Financials | |
$-13.84M |
|
-- |
|
$3.33M |
|
$78.64M |
|
$68.12M |
|
$-10.52M |
|
$11.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.82% |
|
-46.41% |
|
-46.41% |
|
-- |
|
-36.03% |
|
-37.91% |
|
$-13.84M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.24 |
|
0.93 |
|
97.09 |
|
-7.57% |
|
-7.77% |
|
-5.79% |
|
-7.57% |
|
$2.06 |
|
$-0.31 |
|
$-0.31 |
|